IRIS
MANGANO, KATIA DOMENICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.801
EU - Europa 3.727
AS - Asia 3.594
SA - Sud America 725
AF - Africa 637
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 5
Totale 16.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.565
SG - Singapore 1.732
RU - Federazione Russa 1.166
CN - Cina 1.027
IT - Italia 1.007
BR - Brasile 610
IE - Irlanda 480
UA - Ucraina 338
CI - Costa d'Avorio 336
VN - Vietnam 331
CA - Canada 181
DE - Germania 174
FR - Francia 172
KR - Corea 148
SN - Senegal 100
NG - Nigeria 90
SE - Svezia 76
GB - Regno Unito 74
IN - India 66
BD - Bangladesh 54
AR - Argentina 43
FI - Finlandia 41
NL - Olanda 39
PL - Polonia 36
MX - Messico 34
ZA - Sudafrica 26
HK - Hong Kong 25
IQ - Iraq 25
ES - Italia 23
JP - Giappone 23
KE - Kenya 23
EC - Ecuador 22
TR - Turchia 22
UZ - Uzbekistan 22
IR - Iran 21
PK - Pakistan 21
BE - Belgio 18
AT - Austria 15
ID - Indonesia 15
BJ - Benin 14
CH - Svizzera 14
MA - Marocco 13
VE - Venezuela 13
CO - Colombia 10
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
GR - Grecia 8
LT - Lituania 8
AU - Australia 7
CL - Cile 7
MK - Macedonia 7
PE - Perù 7
DZ - Algeria 6
EG - Egitto 6
JO - Giordania 6
LB - Libano 6
NP - Nepal 6
AO - Angola 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
GE - Georgia 5
MY - Malesia 5
PY - Paraguay 5
BG - Bulgaria 4
EU - Europa 4
HU - Ungheria 4
TT - Trinidad e Tobago 4
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
PH - Filippine 3
SA - Arabia Saudita 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
IL - Israele 2
KG - Kirghizistan 2
NO - Norvegia 2
PT - Portogallo 2
RO - Romania 2
SV - El Salvador 2
BB - Barbados 1
BS - Bahamas 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LV - Lettonia 1
MM - Myanmar 1
PA - Panama 1
Totale 16.489
Salva come PNG Salva come JPEG
Città #
Dallas 2.088
Singapore 1.033
Santa Clara 806
Moscow 539
Dublin 480
Chandler 464
San Jose 453
Jacksonville 402
Abidjan 336
Ashburn 325
Catania 288
Chicago 283
Houston 236
Hefei 226
Boardman 213
Beijing 158
Seoul 147
Lauterbourg 131
Cambridge 127
Lawrence 127
Andover 124
Ho Chi Minh City 123
Los Angeles 122
Nanjing 114
Toronto 107
Civitanova Marche 106
Dakar 100
Council Bluffs 80
Des Moines 72
New York 66
Hanoi 62
San Mateo 59
Palermo 53
Wilmington 51
São Paulo 50
Grafing 47
Nanchang 44
Abuja 43
Saint Petersburg 43
Buffalo 41
Lagos 39
Amsterdam 35
Hebei 33
Rome 33
Orem 29
Bremen 28
Lappeenranta 26
Ottawa 26
Tianjin 24
Jiaxing 23
Munich 23
Sant'Antonio Abate 23
Montreal 22
Rio de Janeiro 22
Tokyo 22
Columbus 21
Warsaw 21
Atlanta 20
Changsha 20
Hong Kong 20
Phoenix 20
Stockholm 20
The Dalles 20
Falls Church 19
Johannesburg 19
London 19
Brooklyn 18
Brussels 18
Vercelli 18
Dong Ket 17
Shenyang 16
Washington 16
Boston 15
Chiaramonte Gulfi 15
Haiphong 15
Maletto 15
Nizza di Sicilia 15
Cotonou 14
Frankfurt am Main 14
Baghdad 13
Dhaka 13
Guangzhou 13
Messina 13
Paris 13
San Francisco 13
Belo Horizonte 12
Campinas 12
Denver 12
Mumbai 12
Poplar 12
Augusta 11
Ardabil 10
Brasília 10
Da Nang 10
Leawood 10
Milan 10
Turku 10
Acireale 9
Ankara 9
Bắc Ninh 9
Totale 11.438
Salva come PNG Salva come JPEG
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 414
Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. 281
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 216
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 212
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 197
Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease 197
Rifamycin SV: evaluation of the activity in DNB-induced colitis in rats and on IFNγ production in ConA-stimulated rat splenocytes 189
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 186
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 186
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 181
Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens 181
COMPOSIZIONE PER PREVENIRE O TRATTARE LA SINDROME DELL'OVAIO POLICISTICO E LA SINTOMATOLOGIA CORRELATA 177
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 177
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 172
Composition for the prevention or treatment of polycystic ovary syndrome and its related sumptoms 167
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 167
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 166
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 163
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 159
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 159
Anti-inflammatory and immune regulatory properties of 5-androsten-3 beta,17 beta-diol (HE2100), and synthetic analogue HE3204 implications for treatment of autoimmune diseases 157
Anti-melanoma potential of nitric oxide modified form of HIV inhibitor-saquinavir; cell specific mode of drug action 155
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 152
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 151
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 148
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 148
A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies 147
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 147
Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study 146
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 146
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma 145
Emerging therapeutic targets for the treatment of hepatic fibrosis 144
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 144
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 141
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 140
Detection of BRAF gene mutation in primary choroidal melanoma tissue 139
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 137
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 136
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 136
Activation of group III metabotropic glutamate receptors inhibits the production of RANTES in glial cell cultures 135
Comprehensive Analysis of TSPAN32 Regulatory Networks and Their Role in Immune Cell Biology 134
Anti-COVID-19 Potential of Ellagic Acid and Polyphenols of Punica granatum L 133
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats 133
Altered Expression of TSPAN32 during B Cell Activation and Systemic Lupus Erythematosus 132
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 132
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo 130
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2 129
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 127
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 125
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 123
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 123
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 122
Bone Marrow-Derived Mesenchymal Stem Cells To Augment Liver Regeneration in a Preclinical Model of Acute Liver Failure in Rats 121
Effects of GIT-27NO, a NO-donating compound, on hepatic ischemia/reperfusion injury 121
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 119
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus 116
Atopic Dermatitis as a Multifactorial Skin Disorder. Can the Analysis of Pathophysiological Targets Represent the Winning Therapeutic Strategy? 116
In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models 113
Evaluation of Toll-like Receptor 4 (TLR4) Involvement in Human Atrial Fibrillation: A Computational Study 111
Effects of treatment with the hypomethylating agent 5-aza-2’-deoxycytidine in murine type ii collagen-induced arthritis 110
CAN THE IMMUNOMODULATORY POTENTIAL OF CARBON-OXIDERELEASING MOLECULES BE TRANSLATED INTO THE CLINICAL SETTING AS A NOVEL THERAPEUTIC OPTION FOR THE TREATMENT OF AUTOIMMUNE DISEASES? 107
The dichotomic role of macrophage migration inhibitory factor in neurodegeneration 105
Overexpression of macrophage migration inhibitory factor and its homologue d-dopachrome tautomerase as negative prognostic factor in neuroblastoma 105
Sponge-like macroporous cyclodextrin-based cryogels for controlled drug delivery 104
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 99
GIT-27 NO may be a potential therapeutic agent for melanoma treatment by inhibition of the transcription repressor YIN-YANG 97
The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis 96
Immunomodulatory Effects of Bifidobacterium longum W11 Produced Exopolysaccharide on Cytokine Production 96
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis 96
Immunomodulatory properties of cefaclor: In vivo effect on cytokines release and lymphoprolipherative response on rat 95
Therapeutic potential of carbon monoxide in multiple sclerosis 95
The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy 94
Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND 90
Therapeutic effects of single administration of Cyclophosphamide in rat experimental autoimmune neuritis, a pre-clinical model of autoimmune peripheral neuropathies 90
No-Modified Saquinavir is Equally Efficient Against Doxorubicin Sensitive and Resistant Non-Small Cell Lung Carcinoma Cells/MODIFIKOVANA KOVANA FORMA SAKVINAVIRA EFIKASNO SU PRIMI RA RAST ĆELIJA NESITNOĆELIJSKOG KARCINOMA PLUĆA RAZLIČITE OSETUIVOSTI NA DOKSORUBICIN 90
Therapeutic potential of nitric oxide-modified drugs in colon cancer cells 89
Calcium butyrate: Anti-inflammatory effect on experimental colitis in rats and antitumor properties 89
Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells 89
Modulation of tetraspanin 32 (TSPAN32) expression in T cell-mediated immune responses and in multiple sclerosis 89
Phase II study of the antiretroviral activity and safety of the glucocorticoid receptor antagonist mifepristone in HIV-1-infected patients 88
Prevention and treatment of lethal murine endotoxemia by the novel immunomodulatory agent MFP-14 88
Past, Present and (Foreseeable) Future of Biological Anti-TNF Alpha Therapy 87
Transcriptomic analysis reveals moderate modulation of macrophage migration inhibitory factor superfamily genes in alcohol use disorders 87
Transcriptomic analysis reveals involvement of the macrophage migration inhibitory factor gene network in duchenne muscular dystrophy 87
The immunobiology of apotransferrin in type 1 diabetes 86
Isoproterenol modulates matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor-2 (TIMP-2) in rat parotid gland 86
Effects of combined admistration of imatinib and sorafenib in a murine model of liver fibrosis 86
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor 85
Standardized bovine colostrum derivative impedes development of type 1 diabetes in rodents 85
NO-hybridized protease inhibitors as novel drugs for the treatment of cancer and autoimmune diseases 84
Epigenetic interventions with hypomethylating agent 5-aza-2-deoxycytidine in preclinical models of multiple sclerosis 84
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1 84
Cytotoxic and Immune-Sensitizing Properties of Nitric Oxide-Modified Saquinavir in iNOS-Positive Human Melanoma Cells 83
The role of macrophage migration inhibitory factor in Alzheimer′s disease: Conventionally pathogenetic or unconventionally protective? 83
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barre syndrome and experimental allergic neuritis 82
Novel components of the human metabolome: The identification, characterization and anti-inflammatory activity of two 5-androstene tetrols 82
Saquinavir-NO-targeted S6 protein mediates sensitivity of androgen-dependent prostate cancer cells to TRAIL 81
Expression and localization of prominin-1 in isoproterenol-treated rat parotid gland 81
Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir. 80
Expression of DNA methylation genes in secondary progressive multiple sclerosis 80
Totale 12.895
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.501
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.501
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021191 0 0 0 0 0 0 0 0 0 1 153 37
2021/2022965 98 125 10 21 153 25 138 32 75 9 27 252
2022/20231.621 142 80 27 145 135 250 14 297 392 32 56 51
2023/2024880 55 110 46 64 31 284 8 79 5 30 92 76
2024/20253.256 41 471 192 164 763 316 184 102 230 286 286 221
2025/20267.891 444 1.226 1.477 545 1.049 1.337 808 170 396 439 0 0
Totale 16.728